DNA-PKcs activates the Chk2-Brca1 pathway during mitosis to ensure chromosomal stability

Oncogenesis

Volumn 3, Issue , 2014, Pages

  Shang, Z ^a   Yu, L ^a   Lin, Y F ^a   Matsunaga, S ^b   Shen, C Y ^c   Chen, B P C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TOTTORI UNIVERSITY   (Japan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CHECKPOINT KINASE 2; DNA DEPENDENT PROTEIN KINASE; GAMMA TUBULIN;

ANAPHASE; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KINETOCHORE MICROTUBULE; MITOSIS; MONOUBIQUITINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84893830951     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.49     Document Type: Article

References (56)

1. Bakhoum SF, Compton DA. Chromosomal instability and cancer: a complex relationship with therapeutic potential. J Clin Invest 2012; 122: 1138-1143.
2. Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol 2010; 20: R285-R295.
3. Qi W, Yu H. The spindle checkpoint and chromosomal stability. Genome Dyn 2006; 1: 116-130.
4. Cimini D, Moree B, Canman JC, Salmon ED. Merotelic kinetochore orientation occurs frequently during early mitosis in mammalian tissue cells and error correction is achieved by two different mechanisms. J Cell Sci 2003; 116: 4213-4225. (Pubitemid 37337094)
5. Bakhoum SF, Genovese G, Compton DA. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol 2009; 19: 1937-1942.
6. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009; 460: 278-282.
7. Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA 1998; 95: 2950-2955. (Pubitemid 28135835)
8. Parvin JD. The BRCA1-dependent ubiquitin ligase, gamma-tubulin, and centrosomes. Environ Mol Mutagen 2009; 50: 649-653.
9. Kais Z, Parvin JD. Regulation of centrosomes by the BRCA1-dependent ubiquitin ligase. Cancer Biol Ther 2008; 7: 1540-1543.
10. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006; 34: 1416-1426.
11. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71. (Pubitemid 24345325)
12. Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP et al. BRCA1- dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol 2004; 24: 8457-8466. (Pubitemid 39245068)
13. Sankaran S, Starita LM, Simons AM, Parvin JD. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function. Cancer Res 2006; 66: 4100-4107.
14. Sankaran S, Starita LM, Groen AC, Ko MJ, Parvin JD. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol 2005; 25: 8656-8668. (Pubitemid 41369184)
15. Ahn J, Urist M, Prives C. The Chk2 protein kinase. DNA Repair (Amst) 2004; 3: 1039-1047. (Pubitemid 38997946)
16. Tsvetkov L, Xu X, Li J, Stern DF. Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem 2003; 278: 8468-8475. (Pubitemid 36800598)
17. Stolz A, Ertych N, Kienitz A, Vogel C, Schneider V, Fritz B et al. The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol 2010; 12: 492-499.
18. Wang HC, Chou WC, Shieh SY, Shen CY. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res 2006; 66: 1391-1400.
19. Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT et al. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 2004; 24: 708-718. (Pubitemid 38057922)
20. Zhuang J, Zhang J, Willers H, Wang H, Chung JH, van Gent DC et al. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res 2006; 66: 1401-1408. (Pubitemid 43259920)
21. Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, Qin J et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev 2002; 16: 2333-2338. (Pubitemid 35034402)
22. Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, Morotomi-Yano K et al. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem 2005; 280: 14709-14715. (Pubitemid 40562818)
23. Chen BP, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H et al. Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem 2007; 282: 6582-
24. Lee KJ, Lin YF, Chou HY, Yajima H, Fattah KR, Lee SC et al. Involvement of DNAdependent protein kinase in normal cell cycle progression through mitosis. J Biol Chem 2011; 286: 12796-12802.
25. Shang ZF, Huang B, Xu QZ, Zhang SM, Fan R, Liu XD et al. Inactivation of DNAdependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage. Cancer Res 2010; 70: 3657-3666.
26. Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 2010; 108: 73-112.
27. Stolz A, Ertych N, Bastians H. Loss of the tumour-suppressor genes CHK2 and BRCA1 results in chromosomal instability. Biochem Soc Trans 2010; 38: 1704-1708.
28. Rao CV, Yamada HY, Yao Y, Dai W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis 2009; 30: 1469-1474.
29. Chabalier-Taste C, Racca C, Dozier C, Larminat F. BRCA1 is regulated by Chk2 in response to spindle damage. Biochim Biophys Acta 2008; 1783: 2223-2233.
30. Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci USA 1998; 95: 12983-12988. (Pubitemid 28509510)
31. Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG et al. BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res 2003; 63: 6221-6228. (Pubitemid 37255167)
32. Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML et al. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer 2003; 88: 1285-1291. (Pubitemid 36606348)
33. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 2013; 14: 197-210.
34. Ruchaud S, Carmena M, Earnshaw WC. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007; 8: 798-812. (Pubitemid 47462135)
35. Gregan J, Polakova S, Zhang L, Tolic-Norrelykke IM, Cimini D. Merotelic kinetochore attachment: causes and effects. Trends Cell Biol 2011; 21: 374-381.
36. OConnell CB, Loncarek J, Hergert P, Kourtidis A, Conklin DS, Khodjakov A. The spindle assembly checkpoint is satisfied in the absence of interkinetochore tension during mitosis with unreplicated genomes. J Cell Biol 2008; 183: 29-36.
37. Cimini D. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim Biophys Acta 2008; 1786: 32-40.
38. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999; 3: 389-395. (Pubitemid 29290679)
39. Luders J, Stearns T. Microtubule-organizing centres: a re-evaluation. Nat Rev Mol Cell Biol 2007; 8: 161-167. (Pubitemid 46432528)
40. Chabalier C, Lamare C, Racca C, Privat M, Valette A, Larminat F. BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance. Cell Cycle 2006; 5: 1001-1007.
41. Zhou C, Smith JL, Liu J. Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1. Oncogene 2003; 22: 2396-2404. (Pubitemid 36560723)
42. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56: 816-825. (Pubitemid 26055472)
43. Lampson MA, Cheeseman IM. Sensing centromere tension: Aurora B and the regulation of kinetochore function. Trends Cell Biol 2011; 21: 133-140.
44. Kelly AE, Funabiki H. Correcting aberrant kinetochore microtubule attachments: an Aurora B-centric view. Curr Opin Cell Biol 2009; 21: 51-58.
45. Sankaran S, Crone DE, Palazzo RE, Parvin JD. Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation. Cancer Res 2007; 67: 11186-11194. (Pubitemid 350248543)
46. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih IeM, Vogelstein B et al. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 2002; 99: 16226-16231. (Pubitemid 35462777)
47. Antoni L, Sodha N, Collins I, Garrett MD. CHK2 kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nat Rev Cancer 2007; 7: 925-936. (Pubitemid 350165855)
48. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4: 665-676.
49. Hsu FM, Zhang S, Chen BP. Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment. Transl Cancer Res 2012; 1: 22-34.
50. Shao SL, Cai Y, Wang QH, Yan LJ, Zhao XY, Wang LX. Expression of GLUT-1, p63 and DNA-Pkcs in serous ovarian tumors and their significance. Zhonghua Zhong Liu Za Zhi 2007; 29: 697-700.
51. Lee HS, Choe G, Park KU, Park do J, Yang HK, Lee BL et al. Altered expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during gastric carcinogenesis and its clinical implications on gastric cancer. Int J Oncol 2007; 31: 859-866.
52. Lee HS, Yang HK, Kim WH, Choe G. Loss of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in gastric cancers. Cancer Res Treat 2005; 37: 98-102.
53. Someya M, Sakata K, Matsumoto Y, Yamamoto H, Monobe M, Ikeda H et al. The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis 2006; 27: 117-122. (Pubitemid 43025251)
54. Someya M, Sakata KI, Matsumoto Y, Kamdar RP, Kai M, Toyota M et al. The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer. Br J Cancer 2011; 104: 1724-1729.
55. Ruis BL, Fattah KR, Hendrickson EA. DNA-PKcs regulates proliferation, telomere length and genomic stability in human somatic cells. Mol Cell Biol 2008; 28: 6182-6195.
56. van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol 2011; 731: 237-245.